← Back to IGC

IGC Pharma, Inc. Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 15/05/2026Sep 2025Filed 14/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 15/05/2026Dec 2024Filed 14/02/2025Sep 2024Filed 14/11/2025Jun 2024Filed 14/08/2025
$0.3$0.3$0.2$0.3$0.3$0.3$0.4$0.3
−$2.9−$2.4−$1.8−$1.6−$1.2−$1.8−$1.7−$2.4
−$0.03−$0.02−$0.02−$0.02−$0.02−$0.02−$0.02−$0.03
10098908380787673

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.